LC16m8: An attenuated smallpox vaccine
- 21 April 2006
- Vol. 24 (47-48) , 7009-7022
- https://doi.org/10.1016/j.vaccine.2006.03.087
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- LC16m8, a Highly Attenuated Vaccinia Virus Vaccine Lacking Expression of the Membrane Protein B5R, Protects Monkeys from MonkeypoxJournal of Virology, 2006
- Technical knockout: understanding poxvirus pathogenesis by selectively deleting viral immunomodulatory genesCellular Microbiology, 2004
- Modified Vaccinia Ankara: Potential as an Alternative Smallpox VaccineClinical Infectious Diseases, 2004
- Smallpox Vaccines: Looking Beyond the Next GenerationScience, 2004
- Responses to Smallpox VaccineNew England Journal of Medicine, 2002
- Developing New Smallpox VaccinesEmerging Infectious Diseases, 2001
- Immunological and virological characterization of improved construction of recombinant vaccinia virus expressing rinderpest virus hemagglutininArchiv für die gesamte Virusforschung, 1991
- Improved recombinant LC16m0 or LC16m8 vaccinia virus successfully expressing hepatitis B surface antigenVaccine, 1989
- Genetic Analysis of Vaccinia Virus Lister Strain and Its Attenuated Mutant LC16m8: Production of Intermediate Variants by Homologous RecombinationJournal of General Virology, 1987
- Primary vaccination with an attenuated strain of vaccinia virusArchiv für die gesamte Virusforschung, 1967